OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AV18         View EO 12866 Meetings	Received Date: 05/26/2023
Title: Hospital Outpatient Prospective Payment System: Remedy for 340B-Acquired Drugs Purchased in Cost Years 2018-2022 (CMS-1793)
Agency/Subagency: HHS / CMS	Stage: Proposed Rule
Concluded Action: Consistent with Change	Concluded Date: 07/06/2023
Legal Deadline: Statutory, Judicial	Economically Significant: No
Publication Date: 07/11/2023	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Yes	Small Entities Affected: Businesses, Governmental Jurisdictions
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No